EUVIMEDEUVIMED entdecken
Crossref

Hydrogen Sulfide Ameliorates Heart Aging by Downregulating Matrix Metalloproteinase-9

Kaichuan He, Huaxing Zhang, Bo Tan, Chengqing Song, Zihui Liang, Lixia Zhang, Danyang Tian, Lin Xiao, Hongmei Xue, Qi Guo, Xu Teng, Sheng Jin und 2 weitere

Cardiovascular Drugs and Therapy · 2025-10 · 39 (5) · 967-981

DOI: 10.1007/s10557-024-07586-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 17.06.2024. Verfasst von Kaichuan He und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Hebei Medical University, 050017, Hebei, China. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Hydrogen Sulfide, Aging, Myocardium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hebei Province, the University level Graduate Innovation Funding Project of Hebei Medical University in 2023.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Aging contributes significantly to cardiovascular diseases and cardiac dysfunction, leading to the upregulation of matrix metalloproteinase-9 (MMP-9) in the heart and a significant decrease in hydrogen sulfide (H2S) content, coupled with impaired cardiac diastolic function. This study explores whether supplementing exogenous hydrogen sulfide during aging ameliorates the decline in H2S concentration in the heart, suppresses MMP-9 expression, and improves the age-associated impairment in cardiac morphology and function. METHODS: We collected plasma from healthy individuals of different ages to determine the relationship between aging and H2S and MMP-9 levels through Elisa detection and liquid chromatography-tandem mass spectrometry (LC/MC) detection of plasma H2S content. Three-month-old mice were selected as the young group, while 18-month-old mice were selected as the old group, and sodium hydrosulfide (NaHS) was injected intraperitoneally from 15 months old until 18 months old as the old + NaHS group. Plasma MMP-9 content was detected using Elisa, plasma H2S content, cardiac H2S content, and cystathionine gamma-lyase (CSE) activity were detected using LC/MC, and cardiac function was detected using echocardiography. Heart structure was assessed using hematoxylin and eosin staining, Masone staining was used to detect the degree of cardiac fibrosis, while western blot was used to detect the expression of MMP-9, CSE, and aging marker proteins. Knockdown of MMP-9 and CSE in H9c2 cells using small interfering RNA was carried out to determine the upstream-downstream relationship between MMP-9 and CSE. RESULTS: H2S content in the plasma of healthy individuals decreases with escalating age, whereas MMP-9 level rises with age progression. Aging leads to a decrease in H2S levels in the heart and plasma of mice, severe impairment of cardiac diastolic function, interstitial relaxation, and fibrosis of the heart. Supplementing with exogenous H2S can improve these phenomena. CONCLUSION: H2S maintains the structure and function of the heart by inhibiting the expression of MMP-9 during the aging process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 9Hydrogen SulfideAgingMyocardiumVentricular Function, LeftMyocytes, CardiacAnimalsDown-RegulationMaleCystathionine gamma-LyaseHumansMiceFibrosisMice, Inbred C57BLAge FactorsFemaleSulfides

Stichwörter der Autor:innen

AgingCSEHeartHydrogen sulfideMMP-9

Substanzen

Matrix Metalloproteinase 9Hydrogen SulfideCystathionine gamma-LyaseMmp9 protein, mousesodium bisulfideMMP9 protein, humanSulfides

Autor:innen und Institutionen

  • Department of Physiology, Hebei Medical University, 050017, Hebei, China.
  • Core Facilities and Centers, Hebei Medical University, 050017, Hebei, China.
  • Clinical Pharmacokinetic Laboratory, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, 201203, Shanghai, China.
  • Clinical Practice Teaching Department, Hebei Medical University, 050017, Hebei, China.
  • Department of Medical Laboratory, Hebei Children's Hospital, 050017, Hebei, China.
  • Department of Psychiatry, the First Hospital of Hebei Medical University, 050031, Hebei, China. acxsunny@sina.com.

ORCID-Profile: Yuming Wu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hebei Province
  • the University level Graduate Innovation Funding Project of Hebei Medical University in 2023

Zitieren

APA

He, K., Zhang, H., Tan, B., Song, C., Liang, Z., Zhang, L., Tian, D., Xiao, L., Xue, H., Guo, Q., Teng, X., Jin, S., An, C., & Wu, Y. (2025). Hydrogen Sulfide Ameliorates Heart Aging by Downregulating Matrix Metalloproteinase-9. Cardiovascular Drugs and Therapy, 39(5), 967-981. https://doi.org/10.1007/s10557-024-07586-w

Vancouver

He K, Zhang H, Tan B, Song C, Liang Z, Zhang L, et al. Hydrogen Sulfide Ameliorates Heart Aging by Downregulating Matrix Metalloproteinase-9. Cardiovascular Drugs and Therapy. 2025;39(5):967-981. doi:10.1007/s10557-024-07586-w

BibTeX
@article{He2025,
  author = {He, Kaichuan and Zhang, Huaxing and Tan, Bo and Song, Chengqing and Liang, Zihui and Zhang, Lixia and Tian, Danyang and Xiao, Lin and Xue, Hongmei and Guo, Qi and Teng, Xu and Jin, Sheng and An, Cuixia and Wu, Yuming},
  title = {Hydrogen Sulfide Ameliorates Heart Aging by Downregulating Matrix Metalloproteinase-9},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2025},
  volume = {39},
  number = {5},
  pages = {967--981},
  doi = {10.1007/s10557-024-07586-w}
}
Kostenlos starten →